Julian Sanchez
Researcher

Julian Sanchez

Overview

Discipline

    • Gastrointestinal Oncology
    • Health Outcomes and Behavior

Education & Training

    • Tufts University School of Medicine, MD
    • Cleveland Clinic, Ohio, Research Fellow - Colorectal Surgery
    • University of South Florida, Resident - General Surgery
Research

Dr. Sanchez's research interests are focused on anal cancer and colorectal cancer prevention.  He has a special interest in minority health including Latino and gay populations.

Publications

  • Schabath MB, Curci MB, Kanetsky PA, Vadaparampil ST, Simmons VN, Sanchez JA, Sutton SK, Wheldon C, Quinn GP. Ask and Tell: The Importance of the Collection of Sexual Orientation and Gender Identity Data to Improve the Quality of Cancer Care for Sexual and Gender Minorities. J Oncol Pract. 2017 Aug;13(8):542-546. Pubmedid: 28719237.
  • Shetty G, Sanchez JA, Lancaster JM, Wilson LE, Quinn GP, Schabath MB. Oncology healthcare providers' knowledge, attitudes, and practice behaviors regarding LGBT health. Patient Educ Couns. 2016 Oct;99(10):1676-1684. Pubmedid: 27161166. Pmcid: PMC5527558.
  • Hanna C, Mullinax J, Friedman MS, Sanchez J. Jejunal diverticulosis found in a patient with long-standing pneumoperitoneum and pseudo-obstruction on imaging: a case report. Gastroenterol Rep (Oxf). 2016 Nov;4(4):337-340. Pubmedid: 26220890. Pmcid: PMC5193057.
  • Seydafkan S, Shibata D, Sanchez J, Tran ND, Leon M, Coppola D. Pathology Report: Presacral Noncommunicating Enteric Duplication Cyst. Cancer Control. 2016 Apr;23(2):170-174. Pubmedid: 27218796.
  • Quinn GP, Sanchez JA, Sutton SK, Vadaparampil ST, Nguyen GT, Green BL, Kanetsky PA, Schabath MB. Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA-Cancer J Clin. 2015 Dec;65(5):384-400. Pubmedid: 26186412. Pmcid: PMC4609168.
  • Quinn GP, Schabath MB, Sanchez JA, Sutton SK, Green BL. The importance of disclosure: lesbian, gay, bisexual, transgender/transsexual, queer/questioning, and intersex individuals and the cancer continuum. Cancer. 2015 Apr;121(8):1160-1163. Pubmedid: 25521303. Pmcid: PMC4505934.
  • Chen YJ, Chen MB, Liu AJ, Sanchez J, Tsai P, Liu A. Dosimetric coverage of the external anal sphincter by 3-dimensional conformal fields in rectal cancer patients receiving neoadjuvant chemoradiation: implications for the concept of sphincter-preserving radiation therapy. Biomed Res Int. 2014 Jun;2014. Pubmedid: 25089274. Pmcid: PMC4095991.
  • Patel SS, Nelson R, Sanchez J, Lee W, Uyeno L, Garcia-Aguilar J, Hurria A, Kim J. Elderly patients with colon cancer have unique tumor characteristics and poor survival. Cancer. 2013 Feb;119(4):739-747. Pubmedid: 23011893.
  • Arrington AK, Heinrich EL, Lee W, Duldulao M, Patel S, Sanchez J, Garcia-Aguilar J, Kim J. Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer. Int J Mol Sci. 2012 Sep;13(10):12153-12168. Pubmedid: 23202889 . Pmcid: PMC3497263.
  • Kalady MF, Dejulius KL, Sanchez JA, Jarrar A, Liu X, Manilich E, Skacel M, Church JM. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis. Dis Colon Rectum. 2012 Feb;55(2):128-133. Pubmedid: 22228154.
  • Sanchez JA, Dejulius KL, Bronner M, Church JM, Kalady MF. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer. Inflamm Bowel Dis. 2011 Sep;17(9):1966-1970. Pubmedid: 21618350.
  • Sanchez JA, Dejulius KL, Bronner M, Church JM, Kalady MF. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer. Inflamm Bowel Dis. 2011 Sep;17(9):1966-1970. Pubmedid: 21618350.
  • Messick CA, Sanchez J, Dejulius KL, Hammel J, Ishwaran H, Kalady MF. CEACAM-7: a predictive marker for rectal cancer recurrence. Surgery. 2010 May;147(5):713-719. Pubmedid: 20004437.
  • Messick CA, Sanchez J, Dejulius KL, Hammel J, Ishwaran H, Kalady MF. CEACAM-7: a predictive marker for rectal cancer recurrence. Surgery. 2010 May;147(5):713-719. Pubmedid: 20004437.
  • Sanchez JA, Krumroy L, Plummer S, Aung P, Merkulova A, Kalady MF, DeJulius KL, Manilich E, Church JM, Casey G, Skacel M. Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer. Br J Surg. 2009 Oct;96(10):1196-1204. Pubmedid: 19787768.
  • Kalady MF, Sanchez JA, Manilich E, Hammel J, Casey G, Church JM. Divergent oncogenic changes influence survival differences between colon and rectal adenocarcinomas. Dis Colon Rectum. 2009 Jun;52(6):1039-1045. Pubmedid: 19581844.
  • Messick CA, Sanchez J, Dejulius KL, Church JM, Kalady MF. Genetic and molecular diversity of colon cancer hepatic metastases. Surgery. 2009 Aug;46(2):227-231. Pubmedid: 19628078.
  • Fukuyama R, Niculaita R, Ng KP, Obusez E, Sanchez J, Kalady M, Aung PP, Casey G, Sizemore N. Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription. Oncogene. 2008 Oct;27(46):6044-6055. Pubmedid: 18591935. Pmcid: PMC2574581.
  • Sanchez JA, Vogel JD, Kalady MF, Bronner MP, Skacel M, Church JM. Identifying Lynch syndrome: we are all responsible. Dis Colon Rectum. 2008 Dec;51(12):1750-1756. Pubmedid: 18682882.
  • Sanchez JA, Vogel JD, Kalady MF, Bronner MP, Skacel M, Church JM. Identifying Lynch syndrome: we are all responsible. Dis Colon Rectum. 2008 Dec;51(12):1750-1756. Pubmedid: 18682882.